Literature DB >> 1532802

Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells.

R Yoshioka1, S Shimizu, J Tachibana, Y Hirose, M Fukutoku, Y Takeuchi, S Sugai, T Takiguchi, S Konda.   

Abstract

Interleukin-7 (IL-7) is a growth factor for pro-B cells, pre-B cells, and thymocytes and is known to induce the proliferation of normal human peripheral T cells. Moreover, human B and T acute leukemia cells with immature surface markers proliferate in response to IL-7. Here we describe a case of T-chronic lymphocytic leukemia, in which the leukemic cells showed a proliferative response to human recombinant IL-7 in vitro. The patient was a 74-year-old woman with anemia and thrombocytopenia, whose bone marrow was fibrosed and infiltrated with pathologic cells. Surface markers of the leukemic cells were CD2(+), CD3(+), CD5(+), CD7(+), CD8(+), and CD4(-). Both T-cell receptor beta-chain and gamma-chain genes were found to be rearranged by immunogenotypic analysis. The leukemic cells proliferated in response to IL-7 dose dependently. The DNA synthesis of CLL cells was stimulated by not only IL-7 but also IL-2 and IL-4. The IL-7-induced proliferation was not inhibited by antibodies to IL-2 receptors or the anti-IL-4 antibody. These findings indicate that IL-7 may induce the proliferation of peripheral CD8+ T cells, even on its pathological counterpart.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532802     DOI: 10.1007/bf00918139

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias.

Authors:  C Skjønsberg; B K Erikstein; E B Smeland; S O Lie; S Funderud; K Beiske; H K Blomhoff
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

2.  Regulation of human T cell proliferation by IL-7.

Authors:  R J Armitage; A E Namen; H M Sassenfeld; K H Grabstein
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

3.  Effect of IL-7 on the growth of fetal thymocytes in culture.

Authors:  J D Watson; P J Morrissey; A E Namen; P J Conlon; M B Widmer
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

4.  Murine thymocytes proliferate in direct response to interleukin-7.

Authors:  P J Conlon; P J Morrissey; R P Nordan; K H Grabstein; K S Prickett; S G Reed; R Goodwin; D Cosman; A E Namen
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

5.  Suppressor T cell chronic lymphocytic leukaemia associated with red cell hypoplasia.

Authors:  S Shionoya; M Amano; Y Imamura; K Nakahara; H Okawa
Journal:  Scand J Haematol       Date:  1984-09

6.  Chronic T-cell lymphocytosis with neutropenia: report of a case studied with monoclonal antibody.

Authors:  A C Aisenberg; B M Wilkes; N L Harris; K A Ault; R W Carey
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

7.  Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia.

Authors:  M Eder; O G Ottmann; T E Hansen-Hagge; C R Bartram; S Gillis; D Hoelzer; A Ganser
Journal:  Leukemia       Date:  1990-08       Impact factor: 11.528

8.  Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors.

Authors:  F M Uckun; I Dibirdik; R Smith; L Tuel-Ahlgren; M Chandan-Langlie; G L Schieven; K G Waddick; M Hanson; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  Subtypes of T-cell chronic lymphatic leukemia.

Authors:  D Huhn; E Thiel; H Rodt; G Schlimok; H Theml; P Rieber
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

10.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

Authors:  R G Goodwin; S Lupton; A Schmierer; K J Hjerrild; R Jerzy; W Clevenger; S Gillis; D Cosman; A E Namen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  3 in total

1.  Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.

Authors:  Imtiaz A Khan; Magali Moretto; Xiao-Qing Wei; Martha Williams; Joseph D Schwartzman; Foo Y Liew
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

Review 2.  Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication.

Authors:  Meysam Mosallaei; Miganoosh Simonian; Naeim Ehtesham; Mohammad Reza Karimzadeh; Nasim Vatandoost; Babak Negahdari; Rasoul Salehi
Journal:  Cancer Gene Ther       Date:  2020-05-18       Impact factor: 5.987

3.  Potential implications of interleukin-7 in chronic wound healing.

Authors:  Annie Bartlett; Andrew J Sanders; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Exp Ther Med       Date:  2016-04-18       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.